Title:
【発明の名称】オピオイドジアリールメチルピペラジンおよびピペリジン
Document Type and Number:
Japanese Patent JP3109832
Kind Code:
B2
Abstract:
PCT No. PCT/GB93/00216 Sec. 371 Date Aug. 3, 1994 Sec. 102(e) Date Aug. 3, 1994 PCT Filed Feb. 2, 1993 PCT Pub. No. WO93/15062 PCT Pub. Date Aug. 5, 1993Diarylmethylpiperazine compounds having utility as receptor-binding species, e.g., for mediating analgesia, and for combatting drug addiction, alcohol addiction, and drug overdose. The compounds may be administered orally, rectally, topically, nasally, ophthalmically, or parenterally (subcutaneously, intramuscularly, and intravenously), for veterinary and human use, and include delta receptor and mu receptor binding species.
Inventors:
Chang, Kwen-Jen
Boswell, Gladi Evan
Bubbaku's, Darth Garrido
Collins, Mark Alan
Davis, Anne Otostott
Robert Walton, McNut
Boswell, Gladi Evan
Bubbaku's, Darth Garrido
Collins, Mark Alan
Davis, Anne Otostott
Robert Walton, McNut
Application Number:
JP51307293A
Publication Date:
November 20, 2000
Filing Date:
February 02, 1993
Export Citation:
Assignee:
Delta Pharmaceuticals, Incorporated
International Classes:
A61K31/44; A61K31/4427; A61K31/4433; A61K31/495; A61K38/05; A61P1/00; A61P1/12; A61P11/00; A61P13/02; A61P15/00; A61P25/04; C07D241/04; A61P25/24; A61P25/26; C07D211/70; C07D213/38; C07D213/75; C07D213/82; C07D241/06; C07D277/28; C07D295/03; C07D295/096; C07D295/135; C07D295/155; C07D295/192; C07D333/20; C07D333/28; C07D333/38; C07D401/06; C07D403/10; C07D409/06; C07K5/06; C07K5/065; C07D295/02; (IPC1-7): C07D211/70; A61K31/44; A61K31/495; A61P1/00; A61P1/12; A61P11/00; A61P15/00; A61P25/04; A61P25/24; C07D241/04; C07D241/06
Attorney, Agent or Firm:
Akira Asamura (3 outside)